Authors/Disclosures
|
Ronen R. Leker, MD
|
No disclosure on file |
|
Sara Eyal, PhD
(The Hebrew University of Jerusalem)
|
Dr. Eyal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dexcel Pharma, Israel. Dr. Eyal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trumed. Dr. Eyal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medinet Medical. The institution of Dr. Eyal has received research support from Israel Science Foundation. The institution of Dr. Eyal has received research support from Israel Ministry of Science & Technology. Dr. Eyal has received publishing royalties from a publication relating to health care. Dr. Eyal has received personal compensation in the range of $5,000-$9,999 for serving as a Member of professional committees with Israel Ministry of Health. Dr. Eyal has a non-compensated relationship as a Treatments and Scientific Committees, contributing editor to Epilepsy Currents with AES that is relevant to AAN interests or activities. Dr. Eyal has a non-compensated relationship as a Prioritization, Climate Change Task Forces with ILAE that is relevant to AAN interests or activities. Dr. Eyal has a non-compensated relationship as a Co-Chair, member of the Executive Committee with The Israeli Chapter of the ILAE that is relevant to AAN interests or activities. |
|
Guy Raphaeli, MD
|
No disclosure on file |
|
Roni Eichel, MD
(Department of Neurology)
|
No disclosure on file |
|
Tamir S. Ben-Hur, MD, PhD
(Hadassah Hebrew University Medical Center)
|
The institution of Dr. Ben-Hur has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI Pharma. The institution of Dr. Ben-Hur has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kadimastem. The institution of Dr. Ben-Hur has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sipnose. The institution of Dr. Ben-Hur has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regenera Pharma. The institution of Dr. Ben-Hur has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medasense. Dr. Ben-Hur has received stock or an ownership interest from Sipnose. Dr. Ben-Hur has received stock or an ownership interest from Kadimastem. Dr. Ben-Hur has received stock or an ownership interest from MAPI Pharma. Dr. Ben-Hur has received intellectual property interests from a discovery or technology relating to health care. |
|
|
No disclosure on file |
|
|
No disclosure on file |